{"id":58733,"date":"2016-06-15T16:30:44","date_gmt":"2016-06-15T20:30:44","guid":{"rendered":"https:\/\/rarediseases.org\/nord-appoints-genetics-and-metabolic-specialist-marshall-l-summar-m-d-as-chairman-of-the-board\/"},"modified":"2022-12-01T11:58:05","modified_gmt":"2022-12-01T16:58:05","slug":"nord-appoints-genetics-and-metabolic-specialist-marshall-l-summar-m-d-as-chairman-of-the-board","status":"publish","type":"post","link":"https:\/\/rarediseases.org\/es\/nord-appoints-genetics-and-metabolic-specialist-marshall-l-summar-m-d-as-chairman-of-the-board\/","title":{"rendered":"NORD Appoints Genetics and Metabolic Specialist Marshall L. Summar M.D. as Chairman of the Board"},"content":{"rendered":"<figure id=\"attachment_26744\" aria-describedby=\"caption-attachment-26744\" style=\"width: 200px\" class=\"wp-caption alignleft\"><a href=\"https:\/\/rarediseases.org\/nord-appoints-genetics-metabolic-specialist-marshall-l-summar-m-d-chairman-board\/summar-marshall1\/\" rel=\"attachment wp-att-26744\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-26744 size-medium\" src=\"https:\/\/rarediseases.org\/wp-content\/uploads\/2016\/06\/Summar-Marshall1-200x300.jpg\" alt=\"Summar, Marshall1\" width=\"200\" height=\"300\" \/><\/a><figcaption id=\"caption-attachment-26744\" class=\"wp-caption-text\">Courtesy of Children\u2019s National Health System<\/figcaption><\/figure>\n<p>The National Organization for Rare Disorders (NORD), the leading, independent advocacy organization committed to helping the 1 in 10 Americans with rare diseases, has appointed Marshall L. Summar, M.D., as chairman of the <a href=\"https:\/\/rarediseases.org\/about\/leadership\/board-directors\/\" target=\"_blank\" rel=\"noopener\">board of directors<\/a>. Dr. Summar replaces interim chairman Sheldon Schuster, Ph.D., who will serve as vice chairman.<\/p>\n<p>Dr. Summar is chief of the division of <a href=\"https:\/\/childrensnational.org\/departments\/genetics-and-metabolism\" target=\"_blank\" rel=\"noopener nofollow\">Genetics and Metabolism<\/a>, at <a href=\"https:\/\/childrensnational.org\" target=\"_blank\" rel=\"noopener nofollow\">Children\u2019s National Health System<\/a>, the largest clinical division internationally caring for rare diseases, where he also holds the Margaret O\u2019Malley chair in Genetic Medicine. Dr. Summar\u2019s laboratory works on devices and treatments for patients with genetic diseases and adapting knowledge from rare diseases to mainstream medicine. He also works on newborn screening issues, developing policy, testing and follow-up systems.<\/p>\n<p>\u201cNow is a crucial and exciting time in rare diseases with many opportunities that can both involve and benefit patients,\u201d said Dr. Summar. \u201cI welcome this opportunity to guide NORD on the sustained pursuit of its mission to eliminate challenges for all people affected by the 7,000 known rare diseases, 80 percent of which are genetic-based and less than 5 percent of which have a treatment.\u201d<\/p>\n<p>Since joining its board of directors in 2012, Dr. Summar has also served as chair of NORD\u2019s scientific and medical advisory committee.\u00a0 He is also the chair of the Rare Diseases advisory panel at the Patient-Centered Outcomes Research Institute (PCORI) and serves as president of the board of directors for the Society for Inherited Metabolic Disorders. He is board certified in pediatrics, clinical genetics and biochemical genetics and has been listed in Best Doctor\u2019s in America since 2004.<\/p>\n<p>\u201cSince its founding 33 years ago, NORD and the millions of people we serve have benefited from a board of senior leaders who share our vision of putting the patient first,\u201d said Peter L. Saltonstall, president and CEO of NORD.\u00a0 \u201cWe are pleased to continue this momentum under Dr. Summar as we build upon our resources and services that reflect changes in health care and patient needs.\u201d<\/p>\n<p>NORD is the primary nonprofit organization representing all Americans with rare diseases.\u00a0 Since 1983, NORD has been committed to the identification, treatment and cure of all rare disease through programs of advocacy, education, research, and patient and family services.\u00a0 There are 30 million Americans, more than half of whom are children, living with rare diseases and disorders.<\/p>\n<p><strong>Media Contact:<br \/>\n<\/strong>Jennifer Huron<br \/>\n203.304.7258<br \/>\n<a href=\"mailto:jhuron@rarediseases.org\">jhuron@rarediseases.org<\/a><\/p>\n<p style=\"text-align: center;\"><em>To receive news from NORD, sign up for our monthly email newsletter here.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The National Organization for Rare Disorders (NORD), the leading, independent advocacy organization committed to helping the 1 in 10 Americans with rare diseases, has appointed Marshall L. Summar, M.D., as &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/rarediseases.org\/es\/nord-appoints-genetics-and-metabolic-specialist-marshall-l-summar-m-d-as-chairman-of-the-board\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> \u00abNORD Appoints Genetics and Metabolic Specialist Marshall L. Summar M.D. as Chairman of the Board\u00bb<\/span><\/a><\/p>\n","protected":false},"author":47,"featured_media":12212,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[190,504],"tags":[1156,1155,1026,639,243,928,1157],"class_list":["post-58733","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured-news","category-press-releases","tag-childrens-national-health-system","tag-marshall-l-summar","tag-newborn-screening","tag-pcori","tag-peter-l-saltonstall","tag-press-release","tag-sheldon-schuster"],"acf":[],"_links":{"self":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts\/58733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/users\/47"}],"replies":[{"embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/comments?post=58733"}],"version-history":[{"count":0,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts\/58733\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/media\/12212"}],"wp:attachment":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/media?parent=58733"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/categories?post=58733"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/tags?post=58733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}